Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05763641
TAD After Chemotherapy in Locally Advanced Breast Cancer
Sponsor: Hospital Universitari de Bellvitge
View on ClinicalTrials.gov
Summary
This is an observational study to validate target axillary dissection (TAD) in locally advanced tumors (cN2 and/or cT4).
Official title: Target Axillary Dissection After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
162
Start Date
2021-02-01
Completion Date
2026-06-01
Last Updated
2025-09-10
Healthy Volunteers
No
Interventions
PROCEDURE
Target Axillary Dissection
TAD after neoadjuvant chemotherapy and subsequent axillary lymph node dissection
Locations (2)
Hospital de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain
Hospital Clínico y Provincial de Barcelona
Barcelona, Spain